On behalf of the Council and the Scientific Affairs Committee of the International Society for the Study of Xenobiotics, we are pleased to inform you of an upcoming workshop planned for October 27 – 28, 2016 in Boston, MA entitled, “Translating Preclinical Data to Human Clearance and Pharmacokinetics.” The target audience for this workshop includes scientists from academia, industry, and governmental and regulatory agencies. The workshop will offer an atmosphere for discussion, both formal and informal, conducive to the exchange of information and experiences and will present attendees opportunities to interact with senior leaders in this field.
The two-day workshop features well-known speakers from industry, academia, and regulatory agencies and will address critical challenges in predicting human clearance and pharmacokinetics. Our ability to accurately predict human clearance and pharmacokinetics is an essential component of drug discovery and development. The ultimate goal of the workshop is to facilitate formulation of practical strategies utilized in the pharmaceutical industry on human PK/clearance prediction based on in vitro and animal data in combination with modeling methods.
We hope you will join us and we look forward to seeing you in Boston this October!
|Yingying Guo, PhD
Principal Research Scientist
Eli Lilly & Company
Jin Zhou, PhD
Boehringer Ingelheim Pharmaceuticals, Inc.